| Genomic Medicine |
1 |
1 |
| Rare Diseases |
0 |
0.97 |
| Muscular Dystrophy |
0 |
0.49 |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
0 |
0.41 |
| Huntington Disease |
0 |
0.29 |
| Muscular Atrophy |
0 |
0.29 |
| Myasthenia Gravis |
0 |
0.29 |
| Revenue and Practice Management |
0 |
0.29 |
| Professional Development |
0 |
0.27 |
| Continuing Medical Education |
0 |
0.21 |
| Genetic Testing |
0 |
0.13 |
| Newborn Screening |
0 |
0.13 |
| Academia |
0 |
0.09 |
| Clinical Management |
0 |
0.09 |
| Demyelination |
0 |
0.09 |
| Disease-Modifying Therapy |
0 |
0.09 |
| Dystrophinopathies |
0 |
0.09 |
| Face |
0 |
0.09 |
| Genetics |
0 |
0.09 |
| Medical Education |
0 |
0.09 |
| Medical Literature |
0 |
0.09 |
| Neuromyelitis Optica |
0 |
0.09 |
| Newborn |
0 |
0.09 |
| ReCAP |
0 |
0.09 |
| Referral |
0 |
0.09 |
| Salary and Compensation |
0 |
0.09 |